Your Good Partner in Biology Research

  1. Home
  2. 抗体
  3. 多克隆抗体
  4. FXYD5 Antibody

FXYD5 Antibody

  • 货号：
    CSB-PA842655DSR1HU
  • 规格：
    ￥440
  • 促销：
    小规格抗体限时一口价
  • 图片：
    • Immunohistochemistry of paraffin-embedded human cervical cancer using CSB-PA842655DSR1HU at dilution of 1:100
    • Immunohistochemistry of paraffin-embedded human kidney tissue using CSB-PA842655DSR1HU at dilution of 1:100
  • 其他：

产品详情

  • 产品名称：
    Rabbit anti-Homo sapiens (Human) FXYD5 Polyclonal antibody
  • Uniprot No.：
    Q96DB9
  • 基因名：
    FXYD5
  • 别名：
    FXYD5 antibody; DYSAD antibody; IWU1 antibody; HSPC113 antibody; UNQ2561/PRO6241FXYD domain-containing ion transport regulator 5 antibody; Dysadherin antibody
  • 宿主：
    Rabbit
  • 反应种属：
    Human
  • 免疫原：
    Recombinant Human FXYD domain-containing ion transport regulator 5 protein (22-145AA)
  • 免疫原种属：
    Homo sapiens (Human)
  • 标记方式：
    Non-conjugated
  • 克隆类型：
    Polyclonal
  • 抗体亚型：
    IgG
  • 纯化方式：
    Antigen Affinity Purified
  • 浓度：
    It differs from different batches. Please contact us to confirm it.
  • 保存缓冲液：
    PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
  • 产品提供形式：
    Liquid
  • 应用范围：
    ELISA, IHC
  • 推荐稀释比：
    Application Recommended Dilution
    IHC 1:20-1:200
  • Protocols：
  • 储存条件：
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 货期：
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

产品评价

靶点详情

  • 功能：
    Involved in down-regulation of E-cadherin which results in reduced cell adhesion. Promotes metastasis.
  • 基因功能参考文献：
    1. the ratio between FXYD5 and alpha1-beta1 heterodimer determines whether the Na,K-ATPase acts as a positive or negative regulator of intercellular adhesion. PMID: 27142834
    2. Knockdown of FXYD5 in MDA-MB-231 breast cancer cells largely decreases expression and secretion of the chemokine CCL2 (MCP-1). A related effect has also been observed in renal cell carcinoma cells. PMID: 27006401
    3. Study demonstrated that the expression of FXYD1, FXYD3 and FXYD5 is elevated in the lungs of Acute respiratory distress syndrome patients PMID: 26410457
    4. Dysadherin-silenced side population cells exhibited reduced expression of Bcl-2 and Bax compared with that prior to silencing. PMID: 26458963
    5. we are focusing on the role of dysadherin in E-cadherin downregulation, the various expression patterns of the molecule in head and neck cancer PMID: 22105147
    6. Findings suggest that dysadherin might contribute to breast cancer progression through AKT activation. PMID: 22494103
    7. These results suggest a role of let-7a down-regulation in the development of thyroid neoplasias of the follicular histotype, likely regulating dysadherin protein expression levels. PMID: 22965940
    8. Data show that osteoblasts are the major cell type of the bone marrow that affect RCC cells by secreting factors that increase the expression of dysadherin and CCL2 in the tumor cells leading to enhanced cell migration. PMID: 21328336
    9. This is the first report on expression of dysadherin in the male gonad and in spermatozoa. PMID: 21774927
    10. Overexpression of Snail, Slug, and dysadherin and activation of Wnt and PI3K/Akt signaling was associated with inactivated E-cadherin in the spindle cells of monophasic fibrous synovial sarcomas. PMID: 21809991
    11. Combined dysadherin-positive expression and E-cadherin-negative expression may be valuable information for predicting aggressive tumor behavior of differentiated-type gastric carcinoma with submucosal invasion PMID: 21239043
    12. transfection of dysadherin cDNA into the liver cancer cell line PLC/PRF/5 enhanced the properties of cencer stem cells, including anti-apoptosis, their sphere-forming ability, side population phenotype, and tumor initiation ability in vivo PMID: 20952084
    13. In lung carcinomas dysadherin expression seems to reflect tumour aggressiveness and may be considered a positive marker of poor prognosis when considered alone or/and in combination with down-regulation of E-cadherin. PMID: 20712010
    14. The detection of dysadherin in tumors and cytokeratin in the lymph nodes may be a potential significant indicator of a poor prognosis for patients who undergo complete resection of stage I non-small cell lung cancer PMID: 20944097
    15. We report the cloning and characterization of a cancer-associated cell membrane glycoprotein recognized by mAb NCC-3G10. PMID: 11756660
    16. dysadherin expression was significantly associated with the prognosis, occurrence of secondary undifferentiated carcinomas, size of the primary tumor, and metastasis to the regional lymph nodes and lungs PMID: 12970317
    17. dysadherin has a role in hematogenous metastasis of gastric cancer PMID: 15102690
    18. Dysadherin and E-cadherin expression may help to predict the prognosis of patients with ESCC (esophageal squamous cell carcinoma). PMID: 15459499
    19. Dysadherin is able to modulate actin structures, stimulate cell motility, and contribute directly to the metastatic potential of human pancreatic cancer cells. PMID: 15466191
    20. dysadherin may be a valuable prognostic marker in cervical carcinoma. PMID: 15619642
    21. Over expression of dysadherin is associated with cutaneous malignant melanoma PMID: 15751018
    22. In testicular tumours, as in other neoplasms, dysadherin downregulates E-cadherin expression, at least in part PMID: 16333245
    23. Found in trophoblasts in both normal and abnormal pregnancies. PMID: 17084448
    24. Dysadherin may play an important role in breast cancer progression by promoting invasion. PMID: 17437014
    25. Recent work that has provided insights into possible mechanisms of action of dysadherin in the cancer progression process was reviewed. PMID: 17442482
    26. FXYD5 is upregulated in cystic fibrosis epithelia which may exacerbate the Na(+) hyperabsorption and surface liquid dehydration observed in cystic fibrosis. PMID: 18263667
    27. Increased dysadherin expression is possibly one of the post-transcriptional mechanisms responsible for E-cadherin downregulation in thyroid papillary neoplasia PMID: 18677652
    28. The dysadherin expression level was significantly correlated with gastrointestinal stromal tumor risk stratification. PMID: 19217217

    显示更多

    收起更多

  • 亚细胞定位：
    Membrane; Single-pass type I membrane protein.
  • 蛋白家族：
    FXYD family
  • 数据库链接：

    HGNC: 4029

    OMIM: 606669

    KEGG: hsa:53827

    STRING: 9606.ENSP00000344254

    UniGene: Hs.333418